mRNA Cancer Drug Shows Success in Melanoma Trial

France24 World · world

US drugmakers Merck and Moderna announced a personalised mRNA cancer treatment has successfully reduced melanoma tumor recurrence in a large, late-stage trial. Experts are calling this development a significant breakthrough. This marks the first time an mRNA drug has demonstrated positive results in such a major clinical trial, offering new hope for cancer patients.